Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Molecular investigation of ergot alkaloid ergotamine's modulatory effects on glycine receptors expressed in Xenopus oocytes. Local targets link to admitted publications; unresolved targets remain external evidence.
Glycine receptors and brain development
10.3389/fncel.2013.00184 · 2013 · External reference
10.1021/bi500815f
10.1021/bi500815f · External reference
10.1152/physrev.00042.2003
10.1152/physrev.00042.2003 · External reference
10.1038/s41401-020-00503-5
10.1038/s41401-020-00503-5 · External reference
Glycine receptor autoantibodies impair receptor function and induce motor dysfunction
10.1002/ana.25832 · 2020 · External reference
Expression of glycine receptor subunits in glial cells of the rat spinal cord
10.1046/j.1471-4159.1996.66041383.x · 1996 · External reference
Glycine receptors expression in rat spinal cord and dorsal root ganglion in prostaglandin E2 intrathecal injection models
2018 · External reference
Glycine receptor in hippocampal neurons as a target for action of extracellular cyclic nucleotides
10.1016/j.neulet.2013.12.037 · 2014 · External reference
10.1152/jn.00365.2001
10.1152/jn.00365.2001 · External reference
Involvement of GABA and glycine in recurrent inhibition of spinal motoneurons
10.1152/jn.1992.68.2.397 · 1992 · External reference
10.1523/jneurosci.4420-03.2004
10.1523/jneurosci.4420-03.2004 · External reference
Central nervous system stimulants: basic pharmacology and relevance to anaesthesia and critical care
2023 · External reference
Effects of GABA receptor antagonists on retinal glycine receptors and on homomeric glycine receptor alpha subunits
10.1152/jn.01228.2004 · 2005 · External reference
10.1038/s41401-023-01149-9
10.1038/s41401-023-01149-9 · External reference
10.1093/brain/awx289
10.1093/brain/awx289 · External reference
Glycine receptor subtypes and their roles in nociception and chronic pain
10.3389/fnmol.2022.848642 · 2022 · External reference
Impaired glycine receptor trafficking in neurological diseases
10.3389/fnmol.2018.00291 · 2018 · External reference
10.1016/s0165-6147(02)02138-7
10.1016/s0165-6147(02)02138-7 · External reference
10.1038/nrn2286
10.1038/nrn2286 · External reference
Pyramidal tract and alternate motor fibers complementarily mediate motor compensation in patients after hemispherotomy
10.1038/s41598-020-57504-x · 2020 · External reference
Anatomically revealed morphological patterns of pyramidal neurons in layer 5 of the motor cortex
10.1038/s41598-020-64665-2 · 2020 · External reference
10.1007/978-3-031-36159-3
10.1007/978-3-031-36159-3 · 2023 · External reference
10.1038/s41593-018-0118-0
10.1038/s41593-018-0118-0 · External reference
Blocking glycine receptors reduces neuroinflammation and restores neurotransmission in cerebellum through ADAM17-TNFR1-NF-κβ pathway
10.1186/s12974-020-01941-y · 2020 · External reference
Glycine and glycine receptor signalling in non-neuronal cells
10.3389/neuro.02.009.2009 · 2009 · External reference
Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus
10.1186/s13041-018-0346-y · 2018 · External reference
Glycine signaling in the framework of dopamine-glutamate interaction and postsynaptic density. Implications for treatment-resistant schizophrenia
10.3389/fpsyt.2020.00369 · 2020 · External reference
Modulation of glycine-mediated spinal neurotransmission for the treatment of chronic pain
10.1021/acs.jmedchem.7b00956 · 2017 · External reference
Ginkgolic acid specifically potentiates alpha 1 glycine receptors
10.1186/2193-1801-4-s1-l31 · 2015 · External reference
10.1016/j.neuron.2021.08.019
10.1016/j.neuron.2021.08.019 · External reference
10.1111/j.1469-7793.2001.t01-1-00741.x
10.1111/j.1469-7793.2001.t01-1-00741.x · External reference
10.1038/s41586-021-04022-z
10.1038/s41586-021-04022-z · External reference
10.1016/j.neuron.2008.10.035
10.1016/j.neuron.2008.10.035 · External reference
10.1038/s41467-020-17364-5
10.1038/s41467-020-17364-5 · External reference
Modulation of glycine receptor single-channel conductance by intracellular phosphorylation
10.1038/s41598-020-61677-w · 2020 · External reference
10.1074/jbc.r112.408229
10.1074/jbc.r112.408229 · External reference
10.1016/j.cell.2021.01.026
10.1016/j.cell.2021.01.026 · External reference
10.1016/j.neuron.2012.09.022
10.1016/j.neuron.2012.09.022 · External reference
10.1016/j.mcn.2018.04.003
10.1016/j.mcn.2018.04.003 · External reference
10.1021/acschemneuro.0c00054
10.1021/acschemneuro.0c00054 · External reference
Voltage clamp recordings from Xenopus oocytes
2000 · External reference
Unresolved reference
2020 · External reference
Interactions of metoclopramide and ergotamine with human 5-HT3A receptors and human 5-HT reuptake carriers
10.1038/sj.bjp.0706351 · 2005 · External reference
Permeability of ergot alkaloids across the blood-brain barrier in vitro and influence on the barrier integrity
10.1002/mnfr.201100431 · 2012 · External reference
The application of the neuroprotective and potential antioxidant effect of ergotamine mediated by targeting N-methyl-D-aspartate receptors
10.3390/antiox11081471 · 2022 · External reference
The glycinergic inhibitory synapse
10.1007/pl00000899 · 2001 · External reference
Roles of monoaminergic, glycinergic and GABAergic inhibitory systems in the spinal cord in rats with peripheral mononeuropathy
10.1016/0006-8993(96)00371-x · 1996 · External reference
Regulation of Human Kv1.4 Channel Activity by the Antidepressant Metergoline
10.1248/bpb.b16-00069 · 2016 · External reference
Antioxidative and analgesic effects of naringin through selective inhibition of transient receptor potential vanilloid member 1
2021 · External reference
10.1523/jneurosci.1627-14.2015
10.1523/jneurosci.1627-14.2015 · External reference
10.1016/j.neuropharm.2018.01.041
10.1016/j.neuropharm.2018.01.041 · External reference
10.1038/s41467-022-32594-5
10.1038/s41467-022-32594-5 · External reference
10.1007/s00018-017-2622-x
10.1007/s00018-017-2622-x · External reference
Glycinergic modulation of pain in behavioral animal models
10.3389/fphar.2022.860903 · 2022 · External reference
Nicotinic receptor subtypes and cognitive function
10.1002/neu.10151 · 2002 · External reference
10.1016/j.celrep.2019.12.030
10.1016/j.celrep.2019.12.030 · External reference
10.1172/jci83817
10.1172/jci83817 · External reference
